About the event
The Neuroblastoma Drug Development Strategy (NDDS4) Forum brings together leading researchers, clinicians and patient advocates from around the world to shape the future of neuroblastoma treatment. Building on the success of previous forums, the meeting focuses on identifying promising therapeutic targets, prioritising new treatment approaches and fostering international collaboration to accelerate the development of innovative therapies for children with neuroblastoma.
LifeArc speakers and attendees
- Joe Baxter – Senior Analyst
- Andy Pearson – Chair of Childhood Cancer
- Wendy Ross – Head of Partnerships for Childhood Cancer
Agenda
| Times | Session |
|---|---|
| 9th July – 11:10 | Introduction to Target Selection for Novel Therapeutic Discovery – Andy Pearson and Joe Baxter |
| 9th July – 11:20 | Review of First 3 LifeArc Targets – LifeArc PTDW Team |
| 9th July – 13:30 | Review of Final 3 LifeArc Targets and Voting on Novel Therapeutic Targets – LifeArc PTDW Team |
| 10th July – 14:25 | Closing reflections – Andy Pearson |